These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15248031)

  • 41. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.
    Portela P; Merzoni J; Lindenau JD; Damin DC; Wilson TJ; Roesler R; Schwartsmann G; Jobim LF; Jobim M
    Hum Immunol; 2017 Mar; 78(3):263-268. PubMed ID: 28088355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
    Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.
    Flores AC; Marcos CY; Paladino N; Capucchio M; Theiler G; Arruvito L; Pardo R; Habegger A; Williams F; Middleton D; Fainboim L
    Tissue Antigens; 2007 Jun; 69(6):568-76. PubMed ID: 17498266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
    Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.
    Becker S; Tonn T; Füssel T; Uhrberg M; Bogdanow M; Seifried E; Seidl C
    Hum Immunol; 2003 Feb; 64(2):183-93. PubMed ID: 12559621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
    Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
    Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
    Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
    Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.
    Al Omar S; Middleton D; Marshall E; Porter D; Xinarianos G; Raji O; Field JK; Christmas SE
    Hum Immunol; 2010 Oct; 71(10):976-81. PubMed ID: 20600442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KIR receptors and HLA-C in the maintenance of pregnancy.
    Flores AC; Marcos CY; Paladino N; Arruvito L; Williams F; Middleton D; Fainboim L
    Tissue Antigens; 2007 Apr; 69 Suppl 1():112-3. PubMed ID: 17445181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA alleles determine differences in human natural killer cell responsiveness and potency.
    Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
    McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
    Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
    Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
    Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
    Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
    Front Genet; 2022; 13():845474. PubMed ID: 35273641
    [No Abstract]   [Full Text] [Related]  

  • 59. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
    Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
    Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
    AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.